Sulforaphane suppresses lipopolysaccharide‐ and Pam3CysSerLys4‐mediated inflammation in chronic obstructive pulmonary disease via toll‐like receptors
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory disease of the airway that represents a large global disease burden. Inflammation is a prominent feature of COPD and represents an important target for treatment. Toll‐like receptors (TLRs) are pattern recognition receptors t...
Main Authors: | Xiaoli Zeng, Xiaoju Liu, Hairong Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.13118 |
Similar Items
-
Sulforaphane Protects Cells against Lipopolysaccharide-Stimulated Inflammation in Murine Macrophages
by: Ruheea Taskin Ruhee, et al.
Published: (2019-11-01) -
Chemopreventive Activities of Sulforaphane and Its Metabolites in Human Hepatoma HepG2 Cells
by: Peng Liu, et al.
Published: (2018-05-01) -
Sulforaphane alters the acidification of the yeast vacuole
by: Alexander Wilcox, et al.
Published: (2020-03-01) -
Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane <i>N</i>-acetylcysteine
by: Eun Suk Son, et al.
Published: (2021-06-01) -
The Profile of Toll-like Receptor 2 (TLR2), TLR4 and Their Cytosolic Downstream Signaling Pathway in Common Variable Immunodeficiency (CVID) Patients
by: Laleh Sharifi, et al.
Published: (2018-04-01)